Aspirin has been labeled as a promising agent for colorectal cancer (CRC) prevention, with analyses suggesting low doses can reduce CRC risk as well as CRC recurrence rates. Could daily low-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback